Oppenheimer & Co. Inc. Acquires 20,740 Shares of Doximity, Inc. (NASDAQ:DOCS)

Oppenheimer & Co. Inc. raised its holdings in Doximity, Inc. (NASDAQ:DOCS) by 139.2% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 35,635 shares of the company’s stock after purchasing an additional 20,740 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Doximity were worth $1,553,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. GAMMA Investing LLC lifted its holdings in Doximity by 40.1% during the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock worth $63,000 after buying an additional 412 shares in the last quarter. Van ECK Associates Corp boosted its holdings in Doximity by 19.7% in the second quarter. Van ECK Associates Corp now owns 2,590 shares of the company’s stock valued at $72,000 after acquiring an additional 427 shares during the last quarter. Cornercap Investment Counsel Inc. increased its position in Doximity by 3.2% in the second quarter. Cornercap Investment Counsel Inc. now owns 17,143 shares of the company’s stock worth $479,000 after purchasing an additional 537 shares during the period. Farther Finance Advisors LLC raised its holdings in Doximity by 324.2% during the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after purchasing an additional 603 shares during the last quarter. Finally, Arizona State Retirement System lifted its position in Doximity by 2.4% during the 2nd quarter. Arizona State Retirement System now owns 30,779 shares of the company’s stock valued at $861,000 after purchasing an additional 725 shares during the period. Institutional investors and hedge funds own 87.19% of the company’s stock.

Doximity Trading Down 5.1 %

DOCS opened at $49.40 on Monday. The firm’s fifty day simple moving average is $43.40 and its 200 day simple moving average is $34.25. The stock has a market capitalization of $9.22 billion, a P/E ratio of 56.78, a P/E/G ratio of 4.09 and a beta of 1.30. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $61.75.

Wall Street Analyst Weigh In

DOCS has been the subject of a number of recent research reports. Canaccord Genuity Group reissued a “hold” rating and set a $60.00 price target (up from $40.00) on shares of Doximity in a research note on Wednesday, November 13th. Truist Financial increased their price target on Doximity from $35.00 to $49.00 and gave the company a “hold” rating in a research note on Thursday. Evercore ISI lifted their price objective on Doximity from $34.00 to $45.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Raymond James reissued an “outperform” rating and issued a $65.00 target price (up previously from $37.00) on shares of Doximity in a research note on Friday, November 8th. Finally, Canaccord Genuity Group cut Doximity from a “buy” rating to a “hold” rating and upped their price target for the company from $40.00 to $60.00 in a research note on Wednesday, November 13th. Eleven analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $51.07.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.